Clinical trial
Using a Low Dose of Ketamine vs. Active Placebo in Treating Severe Depression and Suicide
NCT03666390
Study timeline
Study start (estimated)2018-09-10Date precision: day
Registry last updated2018-09-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Major Depressive Disorderunresolved
Interventions
KetamineDRUG · verified · RxNorm: ketamine
MidazolamDRUG · verified · RxNorm: midazolam
Sponsors & collaborators
Taipei Veterans General Hospital, Taiwanlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03666390 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.